The aim of this prospective, nonrandomized clinical trial was to assess whether brimonidine 0.15% alters retinal vascular autoregulation and short-term visual function in 46 patients with ...

Please provide your email address to receive an email when new articles are posted on . Instillation of brimonidine 0.025% proved to be safe and effective in reducing ocular redness of undetermined ...

Topical brimonidine is linked to a significantly increased risk for trabeculectomy failure in patients with glaucoma due to elevated intraocular pressure.

Please provide your email address to receive an email when new articles are posted on . FLORENCE – Latanoprost and brimonidine were equally well tolerated and did not produce significant modifications ...

Introduction Brimonidine 0.2% (Alphagan ®) is a topical alpha-2 agonist widely used as an antihypertensive. There have been occasional reports of systemic adverse effects in children including ...

Learn everything you need to know about Brimonidine-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings ...

Find out how to take Brimonidine (drug) and its dose. Describes the best time to take the drug and precautions if any that should be followed. We recommend consulting your doctor to verify the ...

In 2 short‑term randomised controlled trials (RCTs: n=553) brimonidine tartrate gel was statistically significantly more effective than vehicle gel in reducing erythema in people with a clinical ...

Indication: Mirvaso ® (brimonidine) Topical Gel, 0.33%* is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of ...